| ID | Type | Location (GRCh37) | Location (GRCh38) | Length | GC content |
|---|---|---|---|---|---|
| hsa_chr3_0366400 | Intergenic-Intergenic | chr3:171876895-171877158 | chr3:172159105-172159368 | 264 nt | 0.4962 |
| hsa_FNDC3B_0011600 | Intron-Intron | chr3:171883078-171891308 | chr3:172165288-172173518 | 250 nt | 0.3000 |
| hsa_chr3_0366500 | Intergenic-Intergenic | chr3:171884201-171884383 | chr3:172166411-172166593 | 183 nt | 0.4098 |
| hsa_FNDC3B_0011700 | Intron-Intron | chr3:171887726-171887882 | chr3:172169936-172170092 | 157 nt | 0.3822 |
| hsa_FNDC3B_0011800 | Intron-Intron | chr3:171889344-171889708 | chr3:172171554-172171918 | 365 nt | 0.3918 |
| hsa_chr3_0366600 | Intergenic-Intergenic | chr3:171889664-171889865 | chr3:172171874-172172075 | 202 nt | 0.4010 |
| hsa_FNDC3B_0011900 | Intron-Intron | chr3:171897180-171897378 | chr3:172179390-172179588 | 199 nt | 0.4322 |
| hsa_FNDC3B_0012000 | Intron-Intron | chr3:171901802-171902148 | chr3:172184012-172184358 | 347 nt | 0.3804 |
| hsa_chr3_0366800 | Intergenic-Intergenic | chr3:171902937-171903186 | chr3:172185147-172185396 | 250 nt | 0.3920 |
| hsa_FNDC3B_0012100 | Intron-Intron | chr3:171906021-171933282 | chr3:172188231-172215492 | 250 nt | 0.4280 |
A study in mice demonstrated that the circFNDC3B was significantly downregulated in hearts post-myocardial infarction and in human cardiac tissues of ischemic cardiomyopathy patients, where its overexpression in cardiac endothelial cells increased vascular endothelial growth factor expression, enhanced angiogenic activity, and reduced apoptosis [Tian et al. DOI:10.3390/molecules26041155].